Cargando…

Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections

Effective control of SARS-CoV-2 infection on primary exposure may reveal correlates of protective immunity to future variants, but we lack insights into immune responses before or at the time virus is first detected. We use blood transcriptomics, multiparameter flow cytometry, and T cell receptor (T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chandran, Aneesh, Rosenheim, Joshua, Nageswaran, Gayathri, Swadling, Leo, Pollara, Gabriele, Gupta, Rishi K., Burton, Alice R., Guerra-Assunção, José Afonso, Woolston, Annemarie, Ronel, Tahel, Pade, Corinna, Gibbons, Joseph M., Sanz-Magallon Duque De Estrada, Blanca, Robert de Massy, Marc, Whelan, Matthew, Semper, Amanda, Brooks, Tim, Altmann, Daniel M., Boyton, Rosemary J., McKnight, Áine, Captur, Gabriella, Manisty, Charlotte, Treibel, Thomas Alexander, Moon, James C., Tomlinson, Gillian S., Maini, Mala K., Chain, Benjamin M., Noursadeghi, Mahdad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895494/ https://www.ncbi.nlm.nih.gov/pubmed/35474751 http://dx.doi.org/10.1016/j.xcrm.2022.100557

Ejemplares similares

Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity
por: Altmann, Daniel M., et al.
Publicado: (2023)

Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study
por: Gupta, Rishi K, et al.
Publicado: (2021)

Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection
por: Milighetti, Martina, et al.
Publicado: (2023)

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
por: Manisty, Charlotte, et al.
Publicado: (2021)

Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response
por: Doykov, Ivan, et al.
Publicado: (2022)

Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
por: Reynolds, Catherine J., et al.
Publicado: (2021)

Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection
por: Captur, Gabriella, et al.
Publicado: (2022)

Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection
por: Manisty, Charlotte, et al.
Publicado: (2021)

Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants
por: Reynolds, Catherine J., et al.
Publicado: (2022)

Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
por: Reynolds, Catherine J., et al.
Publicado: (2020)

Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
por: Swadling, Leo, et al.
Publicado: (2021)

HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19
por: Astbury, Stuart, et al.
Publicado: (2022)

COVID-19: PCR screening of asymptomatic health-care workers at London hospital
por: Treibel, Thomas A, et al.
Publicado: (2020)

Asymptomatic health-care worker screening during the COVID-19 pandemic – Authors' reply
por: Treibel, Thomas A, et al.
Publicado: (2020)

Longitudinal assessment of symptoms and risk of SARS-CoV-2 infection in healthcare workers across 5 hospitals to understand ethnic differences in infection risk.
por: Valdes, Ana M., et al.
Publicado: (2021)

Corrigendum to: Decombinator V4: an improved AIRR-C compliant software package for T-cell receptor sequence annotation
por: Peacock, Thomas, et al.
Publicado: (2021)

Decombinator V4: an improved AIRR-C compliant-software package for T-cell receptor sequence annotation?
por: Peacock, Thomas, et al.
Publicado: (2020)

Can T Cells Abort SARS-CoV-2 and Other Viral Infections?
por: Swadling, Leo, et al.
Publicado: (2023)

Diagnostic ‘omics’ for active tuberculosis
por: Haas, Carolin T., et al.
Publicado: (2016)

Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease
por: Pollara, Gabriele, et al.
Publicado: (2021)

Validation of Immune Cell Modules in Multicellular Transcriptomic Data
por: Pollara, Gabriele, et al.
Publicado: (2017)

DC Priming by M. vaccae Inhibits Th2 Responses in Contrast to Specific TLR2 Priming and Is Associated with Selective Activation of the CREB Pathway
por: Le Bert, Nina, et al.
Publicado: (2011)

HIV blocking antibodies following immunisation with chimaeric peptides coding a short N-terminal sequence of the CCR5 receptor
por: Chain, Benjamin M., et al.
Publicado: (2008)

Clinical academic research in the time of Corona: A simulation study in England and a call for action
por: Banerjee, Amitava, et al.
Publicado: (2020)

Persistent T Cell Repertoire Perturbation and T Cell Activation in HIV After Long Term Treatment
por: Turner, Carolin T., et al.
Publicado: (2021)

The clonal structure and dynamics of the human T cell response to an organic chemical hapten
por: Ronel, Tahel, et al.
Publicado: (2021)

Error, reproducibility and sensitivity: a pipeline for data processing of Agilent oligonucleotide expression arrays
por: Chain, Benjamin, et al.
Publicado: (2010)

In Vivo Molecular Dissection of the Effects of HIV-1 in Active Tuberculosis
por: Bell, Lucy C. K., et al.
Publicado: (2016)

Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers
por: Joy, George, et al.
Publicado: (2021)

Quantitative imaging assay for NF-κB nuclear translocation in primary human macrophages
por: Noursadeghi, Mahdad, et al.
Publicado: (2008)

Immunopathogenesis of Severe Sepsis
por: Noursadeghi, Mahdad, et al.
Publicado: (2000)

COVID-19 vaccine boosted immunity against Omicron in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
por: Milojkovic, Dragana, et al.
Publicado: (2022)

Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure
por: Reynolds, Catherine J., et al.
Publicado: (2022)

Interactions between HIV-1 and the Cell-Autonomous Innate Immune System
por: Towers, Greg J., et al.
Publicado: (2014)

Does tuberculosis threaten our ageing populations?
por: Byng-Maddick, Rachel, et al.
Publicado: (2016)

New Insights into the Limitations of Host Transcriptional Biomarkers of Tuberculosis
por: Noursadeghi, Mahdad, et al.
Publicado: (2021)

Toward a more generalizable blood RNA signature for bacterial and viral infections
por: Gupta, Rishi K., et al.
Publicado: (2022)

Tumor Necrosis Factor (TNF) Bioactivity at the Site of an Acute Cell-Mediated Immune Response Is Preserved in Rheumatoid Arthritis Patients Responding to Anti-TNF Therapy
por: Byng-Maddick, Rachel, et al.
Publicado: (2017)

Transcriptional response modules characterise IL-1β and IL-6 activity in COVID-19
por: Bell, Lucy CK, et al.
Publicado: (2020)

Cell‐type‐specific modulation of innate immune signalling by vitamin D in human mononuclear phagocytes
por: Kundu, Rhiannon, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_our2uo12pk0tjgr6k1ncuof6pa